Autism Spectrum Disorders Clinical Trial
Official title:
Study of Developmental Trajectories From Childhood to Adulthood Patients of the Cohort EpiTED: Research for Prognostic Factors Clinical and Biological
Epidemiological studies have shown that a wide range of outcome trajectories exist in ASD, but little is known about their determinant in a long-term perspective. The EpiTED cohort was set-up in order to understand the heterogeneity of developmental trajectories among children with a diagnosis of PDD and the role of clinical, biological and environmental factors in their adaptive outcome. It is one of the rare cohorts involving a long term prospective follow-up based on a large set of variables, and precise phenotypes of the entire autism spectrum.
Purpose: Epidemiological studies have shown that a wide range of outcome trajectories exist
in ASD, but little is known about their determinant in a long-term perspective. The EpiTED
cohort was set-up in order to understand the heterogeneity of developmental trajectories
among children with a diagnosis of PDD and the role of clinical, biological and
environmental factors in their adaptive outcome. It is one of the rare cohorts involving a
long term prospective follow-up based on a large set of variables, and precise phenotypes of
the entire autism spectrum.
Participants: This longitudinal study for which recruitment began between 1997 and 1999, has
initially involved 281 preschool aged children recruited from 5 French areas. They were seen
at 8 (Time 2), 15 (Time 3) and 20 years of age (Time 4), with an average follow-up length of
15 years. At each follow-up, socio-demographical, clinical, developmental and interventional
were collected. At Time 4 (fourth visit), DNA was collected to do a genetic study Findings
to date: The main results show that there were two developmental trajectories from childhood
to adolescence among the cohort leading to very distinct level of adaptive functioning.
Prognosis factors in childhood were the intellectual level, the presence or absence of
language, the autism degree and the absence or presence of epilepsy. During adolescence
there was a negative impact on the quality of life of the parents of the presence of
aberrant behavior and low level functioning, The children included in the cohort were
followed during 15 years and were assessed four times (at 5, 8, 15 and 20 years on average,
see flow chart in figure 1. From 2000 to 2002, 219 of the original group were reassessed
(time 2, T2). At time 3 (T3), between 2007 and 2009, they were 152 to be re-assessed and 106
between 2012 and 2015 (time 4, T4).
;
Intervention Model: Single Group Assignment, Masking: Open Label
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT02625116 -
ELENA Cohort: A Long-term Longitudinal Study in a Pediatric Sample With Autism Spectrum Disorders
|
||
Not yet recruiting |
NCT06381856 -
Improving Participation of Autistic Children and Adolescents in the Habilitation Process
|
||
Recruiting |
NCT02280746 -
Gluten for Autism Spectrum Disorders
|
N/A | |
Completed |
NCT01945957 -
Brain Imaging of Intranasal Oxytocin Treatment in Autism
|
Phase 1 | |
Completed |
NCT01661855 -
A Pilot Study of Riluzole Versus Placebo in the Treatment of Children and Adolescents With ASD
|
Phase 2 | |
Completed |
NCT01780090 -
Handheld Technology for Speech Development in Students With Autism
|
N/A | |
Completed |
NCT01694667 -
Omega-3 Fatty Acids for Hyperactivity Treatment in Autism Spectrum Disorder
|
Phase 2 | |
Completed |
NCT01691066 -
Pivotal Response Treatment for Infants At-Risk for Autism Spectrum Disorder
|
N/A | |
Completed |
NCT01592747 -
Withdrawal Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified Previously Treated With Memantine
|
Phase 2 | |
Active, not recruiting |
NCT01417026 -
Intranasal Oxytocin and Learning in Autism
|
Phase 2 | |
Enrolling by invitation |
NCT01364818 -
Brain Connectivity in Neurodevelopmental Disorders in Response to Treatment
|
N/A | |
Completed |
NCT01695200 -
Omega-3 Fatty Acids in Autism Spectrum Disorders
|
Phase 4 | |
Completed |
NCT02300597 -
Internet-based Support for Young People With ADHD and Autism - a Controlled Study
|
N/A | |
Completed |
NCT01675414 -
Understanding Gastrointestinal Conditions in Children With Autism Spectrum Disorder (ASD)
|
N/A | |
Not yet recruiting |
NCT00695812 -
The Development of Younger Siblings of Children With Autism Now at 10 Years of Age
|
N/A | |
Recruiting |
NCT05910502 -
Project AFECT (Autism Family Empowerment Coaching and Training Program)
|
N/A | |
Completed |
NCT02081027 -
Pilot Study of Riluzole for Drug-Refractory Irritability in Autism Spectrum Disorders
|
Early Phase 1 | |
Completed |
NCT02797379 -
The Development of a Psychoeducational Tool to Manage Anxiety in People With Autism Spectrum Disorders
|
N/A | |
Terminated |
NCT01730079 -
Near Infrared Spectroscopy in Children With Autism and ADHD
|
||
Completed |
NCT01603225 -
Transcranial Direct Current Stimulation and Autism
|